Qué está moviendo el mercado.

Nuwellis GAAP EPS of -$26.24, revenue of $1.97M

* Nuwellis press release [https://seekingalpha.com/pr/20618135-nuwellis-reports-second-quarter-2026-financial-results-and-business-highlights-focused-on] (NUWE [https://seekingalpha.com/symbol/NUWE]): Q2 GAAP EPS of -$26.24. * Revenue of $…

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

MINNEAPOLIS, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Dale Brady as Princip…

Top Biotech Gainers: GCTK On The Move, BHC, CORT Boost FY'26 Outlook, NEOG On Watch

(RTTNews) - Today's top gainers included Glucotrack, whose subsidiary announced progress in the development strategy for LT-100, a novel non-narcotic therapy; Nuwellis, following expanded clinical recognition for its Aquadex therapy; Bausc…

Top Biotech Gainers: NXTC Soars On Merger Deal, BMGL Moves Past Nasdaq Woes, OTLK Awaits FDA Verdict

(RTTNews) - Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently regained Nasdaq compliance; and Outlook…

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

MINNEAPOLIS, June 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, reviews the year-to-date and outlines strategic prioriti…

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces an expanded collaboration with a major S…

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

MINNEAPOLIS , June 08, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces the closing of a public offering of 1,9…

Pre-Market Movers: TNGX, WOK, GOCO Set The Path

(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday, hinting at possible breakout opportunities. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. Price swings ahead of the…

Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course

(RTTNews) - Pre-market trading is offering an early glimpse into biotech stocks likely to attract investor attention this Wednesday. Significant price moves ahead of the opening bell are being driven by clinical trial updates, public and p…

Nuwellis, Inc. Q1 2026 Earnings Call Summary

Nuwellis, Inc. Q1 2026 Earnings Call Summary - Moby Strategic Execution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick.…

Nuwellis (NUWE) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Tuesday, May 12, 2026 at 9 a.m. ET CALL PARTICIPANTS Chairman of the Board — John L. Erb Chief Executive Officer — Leah McMullen Chief Financial Officer — Carisa Schultz Need a quote from a Motley Fool a…

Here are the major earnings before the open Tuesday

Major earnings expected before the bell on Tuesday include: * JD.com (JD [https://seekingalpha.com/symbol/JD]) * Sea Limited (SE [https://seekingalpha.com/symbol/SE]) * D-Wave Quantum (QBTS [https://seekingalpha.com/symbol/QBTS]) * Lithium…

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

MINNEAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it has retained CORE IR, a leading investor r…

Nuwellis, Inc. Q4 2025 Earnings Call Summary

Nuwellis, Inc. Q4 2025 Earnings Call Summary - Moby Executive Narrative Management characterized 2025 as a year of deliberate repositioning rather than a continuation, focusing on strengthening the operating foundation over top-line growth…

Nuwellis (NUWE) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, March 10, 2026 at 9 a.m. ET CALL PARTICIPANTS Chairman of the Board and Chief Executive Officer — John L. ErbChief Financial Officer — Carissa SchultzVice President, Investor Relations — Leah Mc…

Nuwellis (NUWE) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, March 10, 2026 at 9 a.m. ET CALL PARTICIPANTS Chairman of the Board and Chief Executive Officer — John L. Erb Chief Financial Officer — Carissa Schultz Vice President, Investor Relations — Leah…

Here are the major earnings before the open Tuesday

Major earnings expected after the bell on Tuesday include: * NIO (NIO [https://seekingalpha.com/symbol/NIO]) * BioNTech SE (BNTX [https://seekingalpha.com/symbol/BNTX]) * Uranium Energy Corp. (UEC [https://seekingalpha.com/symbol/UEC]) * K…

Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag

Quant rankings for the upcoming earnings calendar show strength in materials and consumer-related names, while several health care, technology, and communication services companies appear among the weakest-scoring stocks. Silver miner Avin…

Nuwellis appoints CFO

Nuwellis (NUWE [https://seekingalpha.com/symbol/NUWE]) on Friday announced [https://seekingalpha.com/pr/20382384-nuwellis-appoints-carisa-schultz-as-chief-financial-officer] the appointment of Carisa Schultz as CFO, effective February 2, 2…

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis, Inc. Schultz brings public company healthcare finance and medical technology experience to support Nuwellis’ next phase of growth MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a medical technology c…

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that it has…

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

MINNEAPOLIS, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on advancing precision cardiorenal care in critical care settings, today announced that it has entered into a Securities Pur…

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change X3 Holdings Co. Ltd. 219,295,202 0.7175 0.4887 0.5131 +0.2461 China SXT Ph…

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

MINNEAPOLIS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the heart and…

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

MINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardio-renal conditions, announced today that a leading Northeastern U.S. childr…

Nuwellis, Inc. Profit Declines In Q3

(RTTNews) - Nuwellis, Inc. (NUWE) announced earnings for third quarter that Dropped, from last year The company's earnings came in at $0.469 million, or $0.56 per share. This compares with $2.35 million, or $73.23 per share, last year. The…

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

MINNEAPOLIS, MN, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the critical interplay between the heart…

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediat…

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Watch the “What This Means” segment here MINNEAPOLIS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it…

Monday's after hours session: top gainers and losers

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66% After the regular…

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

MINNEAPOLIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, announced plans to introduce a new 24-hour circuit for Aquadex therapy in the United States this fall. The new circuit is designed for single-day o…

Nuwellis receives FDA clearance for new size of dual lumen catheter

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $2.93 million, announced Thursday that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen Extende…

Form 8K Nuwellis Inc For: 21 August

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size…

Nuwellis announces non-binding letter of intent to acquire Rendiatech

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $3.3 million and annual revenue of $8.3 million, announced Tuesday that it has entered into a non-binding letter of intent to acquire Rendiatech, Ltd.,…

Nuwellis signs letter of intent to acquire Rendiatech

Nuwellis (NASDAQ:NUWE [https://seekingalpha.com/symbol/NUWE]) has signed a non-binding letter of intent [https://seekingalpha.com/pr/20204874-nuwellis-signs-letter-of-intent-to-explore-acquisition-of-rendiatech-ltd-a-real-time-fluid] to ac…